← Evidence map

ArticleiScience2025

Ocrelizumab transiently alters microbiota and modulates immune response depending on treatment outcome.

Stepan Coufal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41358150